Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06675396

Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients

By using genetic information we could predict the prevalence of mood disorder and response to treatment.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

This prospective cohort study enrols patients with chronic kidney disease and gathers genetic information. By the patient's biochemical information, including genetic information, we could predict the prevalence of mood disorder and response to the antipsychotherapy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • CKD patients aged 18 to 90 years

Exclusion criteria

  • no CKD patients, aged below 18 or above 90 years

Treatment and study plan

Antidepressants

Other

control

Primary outcomes

  1. Prevalence of depression

    Time frame: 10 years

    Prevalence of depression

Study contacts

Contact information is provided by the study sponsor or research team.

Jun Young Lee Lee Jun Young Professor

CONTACT

[email protected]

800-555-5555

Sponsors and collaborators

Lead sponsor

Wonju Severance Christian Hospital

Other

Registry information

Official study title

Cohort Study on the Psychiatric Outcomes and Genetic Associations in Patients With Chronic Kidney Disease

Acronym: CKD

Important dates

Study start
2024
Primary completion
2026
Study completion
2028
First posted
Nov 5, 2024
Registry last updated
Nov 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.